Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Sell
2,364
-522
-18% -$94.6K 0.06% 403
2026
Q1
$425K Sell
2,886
-1,601
-36% -$260K 0.09% 250
2025
Q4
$875K Buy
4,487
+2,356
+111% +$561K 0.2% 74
2025
Q3
$599K Sell
2,131
-13
-0.6% -$3.31K 0.24% 67
2025
Q2
$469K Buy
2,144
+300
+16% +$48.4K 0.22% 92
2025
Q1
$258K Sell
1,844
-409
-18% -$66.6K 0.16% 126
2024
Q4
$376K Buy
2,253
+65
+3% +$11.5K 0.24% 70
2024
Q3
$373K Buy
2,188
+78
+4% +$11.3K 0.24% 69
2024
Q2
$298K Buy
2,110
+116
+6% +$14.4K 0.21% 84
2024
Q1
$250K Sell
1,994
-98
-5% -$11.2K 0.19% 97
2023
Q4
$221K Buy
+2,092
New +$228K 0.19% 100

Other funds holding ORCL

Abel Hall LLC's ORCL Position: Q2 2026 in Review

Abel Hall LLC reduced its Oracle (ORCL) stake by 18% in Q2 2026, selling an estimated $94.6K and leaving 2,364 shares worth $346K. The position accounts for 0.06% of the portfolio, ranked #403.

Abel Hall LLC first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $875K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Abel Hall LLC held 2,364 shares of Oracle worth $346K as of Q2 2026.
  • Abel Hall LLC sold 522 Oracle shares in Q2 2026, an estimated $94.6K.
  • Oracle made up 0.06% of Abel Hall LLC's portfolio in Q2 2026, its #403 holding.
  • Abel Hall LLC first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • Abel Hall LLC's Oracle position peaked at $875K in Q4 2025.
  • 1,379 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.